Expression of oxytocin receptors is greatly reduced in the placenta of heavy mares with retained fetal membranes due to secondary uterine atony.

Authors: Rapacz-Leonard A, Raś A, Całka J, Janowski T E

Journal: Equine veterinary journal

DOI: 10.1111/evj.12426 PubMed: 25640716Log in to save

Summary

# Retained Fetal Membranes in Heavy Mares: An Oxytocin Receptor Problem Retained fetal membranes (RFM) represents a significant clinical challenge in equine reproduction, particularly in draught breeds where incidence exceeds 50%, yet standard oxytocin therapy frequently fails despite the presumed diagnosis of secondary uterine atony. Rapacz-Leonard and colleagues investigated whether oxytocin receptor expression in placental tissue might explain this therapeutic resistance by comparing placentae from heavy mares experiencing RFM with unaffected controls. Their findings revealed substantially reduced oxytocin receptor expression in the placentae of mares with RFM-related secondary atony, suggesting that impaired receptor availability—rather than insufficient oxytocin alone—underpins the condition's resistance to conventional treatment. For practitioners, this work implies that repeated oxytocin injections may prove ineffective when receptor downregulation or dysfunction is the primary pathology, warranting consideration of alternative or adjunctive therapeutic strategies in resistant cases. Understanding the receptor-level basis of RFM in draught mares could reshape clinical protocols and inform more targeted interventions to prevent this potentially life-threatening complication.

Read the full abstract on PubMed

Practical Takeaways

•Oxytocin therapy may be ineffective when fetal membrane retention is accompanied by reduced placental oxytocin receptor expression; alternative treatments should be considered
•Mares at high risk include heavy draught breeds with >50% incidence; practitioners should be prepared with alternative management strategies
•Secondary uterine atony in retained fetal membranes may have a receptor-mediated mechanism rather than purely a muscular weakness issue

Key Findings

•Oxytocin receptor expression is significantly reduced in placental tissue of mares with retained fetal membranes due to secondary uterine atony
•Reduced oxytocin receptor expression may explain why oxytocin treatment sometimes fails in these cases
•Heavy draught mares show an incidence of fetal membrane retention exceeding 50%

Conditions Studied

retained fetal membranessecondary uterine atonyfetal membrane retention in heavy draught mares

Related References

Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses.

Schramme A R, Pinto C R F, Davis J, Whisnant C S, Whitacre M D(2008)Equine veterinary journal

Management of retained fetal membranes by umbilical vessel infusion in mares submitted to elective C-section.

Neto Marcos Eduardo, Curcio Bruna R, Rafael Leandro A, Pivato Giovana M, Silva Gabriela C, Souza Rafaela P, Mousquer Mariana A, Nogueira Carlos E W(2025)Journal of equine veterinary science

Fertility after fetotomy: a clinical study focusing on heavy draft mares.

Raś A, Rapacz-Leonard A, Raś-Noryńska M, Barański W(2014)The Veterinary record

Treatment of Retained Fetal Membranes in the Mare-A Practitioner Survey.

Warnakulasooriya Dinuka N, Marth Christina D, McLeod Jacqueline A, Hanlon David W, Krekeler Natali(2018)Frontiers in veterinary science

Investigation and management of a cluster of cases of equine retained fetal membranes in Highland ponies.

Hudson N P H, Prince D P, Mayhew I G, Watson E D(2005)The Veterinary record